Laetitia Gahimbare | Medicine and Dentistry | Research Excellence Award

Dr. Laetitia Gahimbare | Medicine and Dentistry | Research Excellence Award

World Health Organization in Regional Office for Africa, Republic of the Congo

Dr. Laetitia Gahimbare is a medical doctor specialized in Clinical Pathology and Epidemiology with over 20 years of experience in antimicrobial resistance (AMR) surveillance, laboratory systems strengthening, and public health preparedness across Africa. She currently serves as Technical Officer for AMR Surveillance, Evidence and Laboratory Strengthening at the WHO Regional Office for Africa, providing strategic and hands-on leadership to 47 Member States. A recognized expert in GLASS implementation, AMR/AMU surveillance, laboratory quality management, and One Health approaches, she has extensive experience translating surveillance data into policy-relevant evidence. Her work spans post-outbreak recovery, AMR simulation exercises, capacity building, and multisectoral coordination, with numerous contributions to regional reports, peer-reviewed publications, and policy briefs.

Citation Metrics (Scopus)

200
150
100
50
10
0

Citations
196

Documents
12

h-index
9

Citations

Documents

h-index

View Scopus Profile

Featured Publications

 

Gabriella Teresa Capolupo | Medicine and Dentistry | Excellence in Research Award

Dr. Gabriella Teresa Capolupo | Medicine and Dentistry | Excellence in Research Award

Dr. Gabriella Teresa Capolupo | Università campus bio medico di Roma | Italy

Gabriella Teresa Capolupo is an accomplished surgeon, researcher, and academic with extensive expertise in general, oncological, and digestive surgery. She has built a distinguished career that integrates advanced clinical practice with dedicated teaching and scientific contributions. As a university lecturer and instructor, she actively contributes to academic programs in General Surgery, Urology, Digestive Surgery, Endocrinology and Metabolic Surgery, Emergency Surgery, and Head and Neck Surgery. Her educational roles include formal teaching, clinical tutoring, multidisciplinary course integration, and participation in advanced training initiatives such as postgraduate master programs and summer schools. She also serves as coordinator of the tutoring activities for the School of Specialization in General Surgery, ensuring high-quality mentorship for surgical trainees and supporting their academic and clinical progression. Her academic profile is further strengthened by appointments to evaluation bodies, including doctoral examination committees in translational medicine and oncology. Clinically, Dr. Capolupo’s work is rooted in continuous service at a major university hospital, where she has operated within colorectal, general, and geriatric surgery units. She performs a broad range of surgical procedures with recognized expertise in abdominal oncological surgery using both laparotomic and laparoscopic approaches. Her responsibilities include acting as first surgeon, surgical assistant, and tutor in the operating room, as well as leading emergency surgical teams. She has held roles with functional leadership responsibilities across both permanent and fixed-term appointments. Her research activity is substantial and internationally recognized, with 2,050 citations, 105 scientific documents, and an h-index of 19, reflecting her influence and scholarly impact in the field of surgical sciences. Dr. Capolupo’s professional trajectory demonstrates a strong and consistent commitment to clinical excellence, scientific advancement, and the training of future medical professionals.

Profiles: Scopus | Orcid

Featured Publications

Schiavone, V., Carannante, F., Melone, G., Miacci, V., Costa, G., Taffon, C., Caricato, M., Capolupo, G. T., & Mascianà, G. (2025). Tailoring the management of colonic lipomas: A 10-year experience of surgical and endoscopic resection. Journal of Personalized Medicine, 15(11), 544. https://doi.org/10.3390/jpm15110544

Schiavone, V., Capolupo, G. T., Mascianà, G., Carannante, F., Costa, G., Miacci, V., & Caricato, M. (2025). Non-operative management (NOM) in rectal cancer: Current evidence and future directions. Encyclopedia, 5(4), 165. https://doi.org/10.3390/encyclopedia5040165

Carannante, F., Capolupo, G. T., Barberio, M., Altamura, A., Miacci, V., Scopigno, M. Z., Circhetta, E., Costa, G., Caricato, M., & Viola, M. G. (2024). Evaluation of short-term effects on colorectal surgery elective patients after implementing a patient blood management program: A multicenter retrospective analysis. Journal of Clinical Medicine, 13(15), 4447. https://doi.org/10.3390/jcm13154447

Feola, A., Minotti, C., Marchetti, D., Caricato, M., Capolupo, G. T., Marsella, L. T., & La Monaca, G. (2021). A five-year survey for plastic surgery malpractice claims in Rome, Italy. Medicina, 57(6), 571. https://doi.org/10.3390/medicina57060571

Mascianà, G., Capolupo, G. T., Carannante, F., & Caricato, M. (2019). An omental mass. Any idea? International Journal of Surgery Case Reports, 57, 161–164. https://doi.org/10.1016/j.ijscr.2019.02.019

Catarci, M., Ruffo, G., Borghi, F., Patriti, A., Delrio, P., Scatizzi, M., Mancini, S., Garulli, G., Carrara, A., Pirozzi, F., et al. (2019). Colorectal surgery in Italy: A snapshot from the iCral study group. Updates in Surgery, 71, 515–524. https://doi.org/10.1007/s13304-018-00612-1

Carannante, F., Mascianà, G., Lauricella, S., Caricato, M., & Capolupo, G. T. (2019). Correction to: Skin bridge loop stoma: Outcome in 45 patients in comparison with stoma made on a plastic rod. International Journal of Colorectal Disease, 34(12), 2195–2197. https://doi.org/10.1007/s00384-019-03451-7

Nooshin Tafazoli | Medicine and Dentistry | Best Researcher Award

Dr. Nooshin Tafazoli | Medicine and Dentistry | Best Researcher Award

Dr. Nooshin Tafazoli | Stanford University | United States

Dr. Nooshin Tafazoli is a physician-scientist with expertise in pediatric nephrology, urology, and regenerative medicine. She earned her Doctor of Medicine degree from Mashhad University of Medical Sciences, where she investigated vesicoureteral reflux and renal scar formation in children. Currently, she is a Visiting Scholar at Stanford University’s Urology Department, where her work integrates translational research, molecular biology, and clinical medicine. With multiple publications in international journals, she has contributed significantly to pediatric kidney disease, urinary tract infection, and novel regenerative treatments. Her career reflects a deep commitment to patient care, medical research, and advancing evidence-based clinical practices.

Profile

Google Scholar

Education

Dr. Tafazoli pursued her Doctor of Medicine (MD) at Mashhad University of Medical Sciences, completing her thesis on the clinical course of vesicoureteral reflux and renal scarring in children. She simultaneously gained experience as a research associate in nephrology and urology. She later advanced her academic journey by joining Tehran University of Medical Sciences’ Pediatric Urology and Regenerative Medicine Research Center, where she contributed to translational medicine projects. Currently, she is affiliated with Stanford University as a Visiting Scholar, engaging in advanced laboratory and clinical research. Her education reflects strong integration of medicine, surgery, and applied biomedical sciences.

Experience

Dr. Tafazoli’s career includes rich clinical and academic experiences. She served as a primary care physician in Mashhad, managing pediatric and urologic patients while also contributing to clinical research. At Tehran University, she engaged in regenerative medicine, assisting in patient care, animal model studies, and manuscript preparation. Later, she joined Stanford University as a Visiting Scholar, where she contributed to pioneering studies on circadian bladder gene networks, cystoscopy outcomes, and translational urology research. Across her roles, she has blended patient interaction with laboratory innovation, strengthening her multidisciplinary expertise in both clinical and academic medical sciences.

Research Interest

Her research interests lie at the intersection of pediatric nephrology, urology, regenerative medicine, and artificial intelligence in healthcare. She has explored machine learning applications in predicting vesicoureteral reflux outcomes, clinical trials in male infertility, and novel biologic scaffolds for pediatric urologic conditions. At Stanford, she continues to investigate circadian gene regulation, bladder pain syndrome, and advanced imaging for clinical diagnostics. She is also committed to improving long-term outcomes in children with recurrent urinary tract infections. By bridging laboratory findings with clinical applications, her research reflects a strong dedication to innovation and improving healthcare for vulnerable pediatric populations.

Award

Dr. Tafazoli has gained recognition through conference presentations, research contributions, and leadership in academic medicine. She presented at prestigious international congresses such as the Iranian Society of Organ Transplantation and Pediatric Nephrology meetings, where her findings on urinary tract infections and renal scarring were highly regarded. Her collaborative publications in high-impact journals demonstrate her growing influence in medical research. Her nomination for the Best Researcher Award reflects her strong academic contributions, patient-centered clinical research, and innovation in regenerative therapies. These achievements establish her as an emerging leader in global medicine and translational research.

Publication Top Notes

Diagnostic Values of Kidney Ultrasonography for Vesicoureteral Reflux (VUR) and High-Grade VUR

Journal: Iranian Journal of Kidney Diseases (2021)

Authors: Naseri M, Bakhtiari E, Tafazoli N, Alamdaran SA, Tafazoli N

Prevalence of Vesicoureteral Reflux in Children with Urinary Tract Infection

Journal: Saudi Journal of Kidney Diseases and Transplantation (2022)

Authors: Naseri M, Aghatabi E, Tafazoli N, Tafazoli N

Evaluating the Correlation Between Serum PSA Values and Gleason Score of Prostate Carcinoma with Ga68-PSMA Uptake in Prostate Tumor in Primary Staging

Journal: Translational Research in Urology (2024)

Authors: Aghaee A, Soltani S, Ghorbani H, Kabiri M, Tafazoli N, Dadgar H, Bakhshi Golestani Z, Norouzbeigi N, Dabbagh V, Sadeghi R, Momeni A

Urinary Tract Infections with Non-Escherichia coli Pathogens in Children: An Observational Study

Journal: Nephro-Urology Monthly (2020)

Authors: Naseri M, Sarvari GR, Tafazoli N, Tafazoli N

Etiologies and Types of Urinary Tract Infection in Children: A Comparison Between Genders

Journal: Pediatric Nephrology (Conference Abstract) (2016)

Authors: Tafazoli N, Naseri M

Conclusion

Dr. Nooshin Tafazoli is an accomplished physician-scientist whose expertise spans clinical practice, medical education, and innovative research. Her contributions in nephrology, urology, and regenerative medicine demonstrate her commitment to improving pediatric health outcomes worldwide. By integrating artificial intelligence, clinical trials, and translational research, she has advanced new diagnostic and therapeutic strategies. Her ongoing work at Stanford University positions her at the forefront of urology and regenerative medicine. Recognized internationally through publications and conference presentations, Dr. Tafazoli embodies the qualities of a promising leader in medicine and an outstanding candidate for prestigious research awards.

Nicola Cosentino | Medicine and Dentistry | Breakthrough Research Award

Dr. Nicola Cosentino | Medicine and Dentistry | Breakthrough Research Award

Dr. Nicola Cosentino | Centro Cardiologioco Monzino | Italy

Dr. Nicola Cosentino is a distinguished Italian cardiologist and researcher whose clinical and scientific contributions have significantly advanced the field of cardiovascular medicine. His career reflects a seamless integration of clinical excellence, research innovation, and academic leadership. With extensive expertise in acute coronary syndromes, perioperative cardiology, and intensive cardiac care, Dr. Cosentino has demonstrated a lifelong commitment to improving patient care through evidence-based medicine and cutting-edge research. His dedication is further underscored by his leadership roles within leading medical institutions and international collaborations, which have allowed him to shape both clinical practice and future research directions. Through a holistic approach that combines patient care, translational science, and teaching, Dr. Cosentino stands as a leading figure in cardiology whose work continues to impact patients, students, and the global medical community. His professional journey represents excellence, perseverance, and innovation in cardiovascular healthcare.

Profiles

Scopus
Orcid

Education

Dr. Nicola Cosentino reflects a trajectory of distinction and excellence in the medical sciences. His educational journey began with a diploma from the Classical High School in Italy, where he graduated with the highest honors, demonstrating early intellectual rigor and dedication. He subsequently earned his medical degree from the Sacred Heart Catholic University of Rome, graduating with full honors and recognition for his thesis on eosinophils in coronary atherosclerosis, conducted under the mentorship of world-renowned cardiology experts. He further specialized in cardiology with distinction at the same institution, completing his specialization with highest marks for a thesis on monocyte-derived macrophages in ischemic heart disease. To deepen his scientific expertise, Dr. Cosentino pursued a PhD in Translational Medicine at the University of Milan, consolidating his commitment to bridging laboratory science with clinical practice. His comprehensive educational training represents a balanced blend of clinical mastery and research excellence.

Experience

Dr. Nicola Cosentino has established an outstanding career marked by diverse clinical and leadership roles within some of Italy’s most prestigious medical institutions. His early professional development was shaped at the Centro Cardiologico Monzino, Milan, where he developed a strong clinical foundation in managing acute and chronic ischemic heart diseases, as well as high-risk cardiovascular conditions. Over the years, he has progressed through key roles, including staff cardiologist, head of the Acute Coronary Syndrome Unit, and medical lead manager of the Italian cardiovascular team at AstraZeneca. Most recently, he was appointed head of the Peri-Operative Cardiology Unit at Centro Cardiologico Monzino, where he now leads advanced clinical programs integrating perioperative assessment, risk management, and innovative therapeutic strategies. His professional journey combines patient care, organizational leadership, and scientific guidance, demonstrating a career that consistently bridges cutting-edge cardiology with practical, patient-centered applications in both hospital and industry settings.

Research Interest

Dr. Cosentino are centered on understanding and addressing the mechanisms underlying coronary artery disease and heart failure, both in acute and chronic presentations. His work has focused extensively on identifying novel biomarkers and molecular pathways that influence the diagnosis, prognosis, and management of these conditions. Special emphasis has been placed on investigating the role of diabetes mellitus, renal impairment, and multi-organ involvement in cardiovascular disease progression. His research also explores the clinical significance of myocardial remodeling and inflammation in acute coronary syndromes, as well as the role of advanced cardiovascular monitoring technologies. By integrating molecular science with patient-focused clinical research, Dr. Cosentino continues to contribute valuable insights into translational cardiology. His long-standing dedication has positioned him as a leading voice in precision medicine approaches, aiming to personalize treatment strategies and improve outcomes for patients facing life-threatening cardiovascular events.

Awards & Recognitions

Dr. Cosentino’s research achievements is reflected in his numerous awards and competitive research grants. His early career excellence was acknowledged through support from the Fondazione Umberto Veronesi, funding projects that examined monocyte-derived macrophages and coronary plaque morphology in ischemic heart disease. He was further awarded competitive grants from the Italian Ministry of Health, including the prestigious “Giovani Ricercatori” program for his PROMISE study on myocardial infarction and non-obstructive coronary arteries, and later through a national PNRR project exploring mitochondrial targets for stroke treatment. These recognitions highlight the innovative and impactful nature of his work, aligning with global efforts to improve cardiovascular diagnostics and therapy. Beyond financial grants, he has been entrusted with leadership positions in scientific societies and advisory committees, reflecting confidence in his scientific judgment. Collectively, these awards affirm his role as a rising leader whose contributions hold significant promise for the future of cardiovascular medicine.

Publication Top Notes

Prognostic Impact of Percutaneous Coronary Intervention in Older Patients Hospitalized with Acute Myocardial Infarction: Real-World Findings from the Lombardy Health Database

Journal: Journal of Clinical Medicine 
Authors: Giancarlo Marenzi, Nicola Cosentino, Marta Resta, Claudia Lucci, Alice Bonomi, Filippo Trombara, Michele Della Rocca, Paolo Poggio, Olivia Leoni, Francesco Bortolan et al.

Impact of Prior Statin Therapy on In-Hospital Outcome of STEMI Patients Treated with Primary Percutaneous Coronary Intervention

Journal: Journal of Clinical Medicine 
Authors: Oreste Lanza, Nicola Cosentino, Claudia Lucci, Marta Resta, Mara Rubino, Valentina Milazzo, Monica De Metrio, Filippo Trombara, Jeness Campodonico, José Pablo Werba et al.

Mitochondrial Biomarkers in Patients with ST-Elevation Myocardial Infarction and Their Potential Prognostic Implications: A Prospective Observational Study

Journal: Journal of Clinical Medicine
Authors: Nicola Cosentino; Jeness Campodonico, Marco Moltrasio, Claudia Lucci, Valentina Milazzo, Mara Rubino, Monica De Metrio, Ivana Marana; Marco Grazi, Alice Bonomi et al.

Acute Kidney Injury in Diabetic Patients With Acute Myocardial Infarction: Role of Acute and Chronic Glycemia

Journal: Journal of the American Heart Association 
Authors: Giancarlo Marenzi, Nicola Cosentino, Valentina Milazzo, Monica De Metrio, Mara Rubino, Jeness Campodonico, Marco Moltrasio, Ivana Marana, Marco Grazi, Gianfranco Lauri et al.

Association Between Haptoglobin Phenotype and Microvascular Obstruction in Patients With ST-Segment Elevation Myocardial Infarction: A Cardiac Magnetic Resonance Study

Journal: JACC: Cardiovascular Imaging 
Authors: Gianluca Pontone, Daniele Andreini, Andrea I. Guaricci, Marco Guglielmo, Andrea Baggiano, Giuseppe Muscogiuri, Laura Fusini, Fabio Fazzari, Claudio Berzovini, Annalisa Pasquini et al.

Conclusion

Dr. Nicola Cosentino represents an exemplary candidate for recognition in the field of cardiology. His career is distinguished by a rare combination of clinical mastery, academic excellence, and innovative research. From his early achievements as a top graduate to his leadership roles in hospital cardiology units and industry, he has consistently demonstrated a vision to improve cardiovascular care through science and compassion. His research outputs have shaped understanding of acute coronary syndromes, myocardial remodeling, and multi-organ interactions, with direct implications for clinical practice and patient outcomes. Furthermore, his dedication to education, mentorship, and collaboration within international networks highlights his commitment to shaping the future of cardiovascular medicine. Through his pioneering research, impactful publications, and leadership contributions, Dr. Cosentino embodies the qualities of a transformative clinician-scientist. He stands as an ideal nominee for prestigious recognition, with a career that continues to inspire innovation and excellence in cardiovascular healthcare.